NCT00262951 arm group bd3633cc5afa4013044f755004f4e05d [clinicaltrials_resource:NCT00262951/arm-group/bd3633cc5afa4013044f755004f4e05d]
recombinant interferon alfa [clinicaltrials_resource:057ed19c236d71c4357bfae2c1ec2c78]radiation therapy [clinicaltrials_resource:5b1327ca455ddcfa6d01a37a21f49973]cisplatin [clinicaltrials_resource:5c1d5a073c41604472e463ea8c9a69ac]Resection of tumor [clinicaltrials_resource:6d9123f6baaa8716b1659cc584ab1929]fluorouracil [clinicaltrials_resource:a785c01bc74975669ed80fc2fbe4a1ef]clinicaltrials:NCT00262951
arm group [clinicaltrials_vocabulary:arm-group]
NCT00262951 arm group bd3633cc5afa4013044f755004f4e05d [clinicaltrials_resource:NCT00262951/arm-group/bd3633cc5afa4013044f755004f4e05d]
Bio2RDF identifier
NCT00262951/arm-group/bd3633cc5afa4013044f755004f4e05d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 3633cc5afa4013044f755004f4e05d
description [clinicaltrials_vocabulary:description]
Pancreatic Adenocarcinoma Pati ...... nd radiation (and or surgery).
identifier
clinicaltrials_resource:NCT00262951/arm-group/bd3633cc5afa4013044f755004f4e05d
title
NCT00262951 arm group bd3633cc5afa4013044f755004f4e05d
@en
type
label
NCT00262951 arm group bd3633cc ...... 633cc5afa4013044f755004f4e05d]
@en